• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Molecular Data Inc. Announces Changes of Chief Financial Officer

    12/2/20 7:00:00 AM ET
    $MKD
    Business Services
    Consumer Discretionary
    Get the next $MKD alert in real time by email

    SHANGHAI, China, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Molecular Data Inc. (“Molecular Data” or the “Company”) (Nasdaq: MKD), a leading technology-driven platform in China’s chemical industry, today announced that the Company has appointed Mr. Steven Foo as the new chief financial officer, effective December 1, 2020. Mr. Zhaohong Li has tendered his resignation as chief financial officer, for personal reasons.

    “We greatly appreciate the contributions that Zhaohong has made during his tenure with the Company, leading our IPO, and building a public company finance team. We respect Zhaohong’s decision and wish him the very best in his future pursuits,” said Dr. Dongliang Chang, Founder and Chairman of the Board of Directors.

    “Steven has an extensive finance background, and operating experience in key international markets. Coupled with his analyst and asset management background and his strategic transaction expertise, I believe Steven will help Molecular Data accelerate in its next phase of growth,” Dr. Chang added.

    Mr. Foo brings over 24 years of investment, financing experience as well as financial management and restructuring work experience in Asia. Previously, Mr. Foo served as a member of the board of directors and chief financial officer of SOS Health Rescue Services. Prior to that, Mr. Foo served as a member of the board of directors and chief financial officer of Hebron Technology. Mr. Foo is a Fellow Chartered Accountant and Certified Public Accountant (CPA). In addition to his experience in securities laws and regulations compliance, Mr. Foo has extensive leadership experience in strategy, financial management and capital markets.

    About Molecular Data Inc.

    Molecular Data Inc. is a leading technology-driven platform in China’s chemical industry, connecting participants along the chemical value chain through integrated solutions. The Company delivers e-commerce solutions, financial solutions, warehousing and logistics solutions, and SaaS suite that are intended to solve pain points for participants in the traditional chemical industry. Built upon a comprehensive knowledge engine and artificial intelligence (AI) capabilities, the Company’s e-commerce solutions are mainly offered through its online platform, consisting of molbase.com, molbase.cn, Moku Data WeChat account, Chemical Community APP and other ancillary platforms.

    For investor and media inquiries, please contact:

    In China:

    Molecular Data Inc.
    Eva Ma
    Tel: +86-21-6495-6998*8130
    E-mail: [email protected]

    The Piacente Group, Inc.
    Emilie Wu
    Tel: +86-21-6039-8363
    E-mail: [email protected]

    In the United States:

    The Piacente Group, Inc.
    Brandi Piacente
    Tel: +1-212-481-2050
    E-mail: [email protected] 


    Get the next $MKD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MKD

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MKD
    SEC Filings

    See more
    • SEC Form 25-NSE filed by Molecular Data Inc.

      25-NSE - Molecular Data Inc. (0001758736) (Subject)

      10/27/22 9:15:54 AM ET
      $MKD
      Business Services
      Consumer Discretionary
    • SEC Form 6-K filed by Molecular Data Inc.

      6-K - Molecular Data Inc. (0001758736) (Filer)

      5/27/22 5:00:13 PM ET
      $MKD
      Business Services
      Consumer Discretionary
    • SEC Form 6-K filed by Molecular Data Inc.

      6-K - Molecular Data Inc. (0001758736) (Filer)

      5/20/22 11:58:23 AM ET
      $MKD
      Business Services
      Consumer Discretionary

    $MKD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Molecular Data Inc. Receives NASDAQ Notification

      SHANGHAI, June 24, 2022  /PRNewswire/ -- Molecular Data, Inc. ("Molecular Data" or the "Company") (NASDAQ:MKD), a technology-driven platform in China, announced that it had received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that to date, it has not regained compliance with the Rule 5250(c)(1). Since the Company is already before a Hearings Panel for its failure to comply with the $1.00 minimum bid price requirement set forth in Listing Rule 5550(a)(2),pursuant to Listing Rule 5810(d)(2), rather than submit a compliance plan for Staff's review, the Company is to address the matter before the Hearings Panel. About Molecular Data, Inc. Molecular Data Inc. is a

      6/24/22 5:15:00 PM ET
      $MKD
      Business Services
      Consumer Discretionary
    • Molecular Data Inc. Receives NASDAQ Notification Regarding Minimum Bid Requirements

      SHANGHAI, May 27, 2022 /PRNewswire/ -- Molecular Data, Inc. ("Molecular Data" or the "Company") (NASDAQ:MKD), a technology-driven platform in China, announced today that on May 25, 2021, it had received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that its minimum closing bid price per share for its ordinary shares had fallen below $1.00 for a period of 30 consecutive business days and that the Company did not meet the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2). On November 29, 2021, the Company was provided with an additional 180 calendar day compliance period, or until May 23, 2022, to demonstrate compliance. On May 24, 2022, th

      5/27/22 10:53:00 PM ET
      $MKD
      Business Services
      Consumer Discretionary
    • Molecular Data Inc. Announces ADS Ratio Change

      SHANGHAI, May 20, 2022 /PRNewswire/ -- Molecular Data Inc. (NASDAQ:MKD) (the "Company") announced today a ratio change on its American Depositary Shares ("ADS") from the current one (1) ADS representing three (3) Class A ordinary shares to the new ratio of one (1) ADS representing forty-five (45) Class A ordinary shares (the "Ratio Change"). The effective date of the Ratio Change is expected to be May 23, 2022. Each ADS holder of record at the close of business on the date when the change in ADS ratio is effective will be required to surrender and exchange every fifteen (15) existing ADSs then held for one (1) new ADS. JPMorgan Chase Bank, N.A., as the depositary bank for the Company's ADS p

      5/20/22 12:14:00 PM ET
      $MKD
      Business Services
      Consumer Discretionary

    $MKD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Molecular Data Inc.

      SC 13G - Molecular Data Inc. (0001758736) (Subject)

      2/5/24 9:48:58 PM ET
      $MKD
      Business Services
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Molecular Data Inc. (Amendment)

      SC 13G/A - Molecular Data Inc. (0001758736) (Subject)

      10/5/23 12:01:56 PM ET
      $MKD
      Business Services
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Molecular Data Inc. (Amendment)

      SC 13G/A - Molecular Data Inc. (0001758736) (Subject)

      2/9/23 9:25:36 PM ET
      $MKD
      Business Services
      Consumer Discretionary

    $MKD
    Leadership Updates

    Live Leadership Updates

    See more
    • WATERDROP ANNOUNCES APPOINTMENT OF NEW INDEPENDENT DIRECTOR

      BEIJING, May 2, 2022 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE:WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced the appointment of Mr. Ning Zhu as a new independent director to its board of directors (the "Board") and the resignation of Mr. Peng Shen as a member of the audit committee of the Board, both effective May 2, 2022. Mr. Zhu will also serve as a member of the audit committee of the Board. After the change, the Board will consist of nine members, three of whom are independent directors, and the audit committee will consist solely of independent directors. Mr. Ning Zhu has b

      5/2/22 8:00:00 AM ET
      $MKD
      $WDH
      Business Services
      Consumer Discretionary
      Specialty Insurers
      Finance
    • Molecular Data Inc. Announces Changes of Chief Financial Officer

      SHANGHAI, China, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Molecular Data Inc. (“Molecular Data” or the “Company”) (Nasdaq: MKD), a leading technology-driven platform in China’s chemical industry, today announced that the Company has appointed Mr. Steven Foo as the new chief financial officer, effective December 1, 2020. Mr. Zhaohong Li has tendered his resignation as chief financial officer, for personal reasons. “We greatly appreciate the contributions that Zhaohong has made during his tenure with the Company, leading our IPO, and building a public company finance team. We respect Zhaohong’s decision and wish him the very best in his future pursuits,” said Dr. Dongliang Chang, Founder and Chair

      12/2/20 7:00:00 AM ET
      $MKD
      Business Services
      Consumer Discretionary